A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol

Bibliographic Details
Main Authors: Ma, Xiao-Wei, Guo, Xiao-Hui, Xiao, Xin-Hua, Guo, Li-Xin, Lv, Xiao-Feng, Li, Quan-Min, Gao, Yan
Format: Online
Language:English
Published: Science Press 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470020/
id pubmed-3470020
recordtype oai_dc
spelling pubmed-34700202012-10-24 A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol Ma, Xiao-Wei Guo, Xiao-Hui Xiao, Xin-Hua Guo, Li-Xin Lv, Xiao-Feng Li, Quan-Min Gao, Yan Research Articles Science Press 2012-09 /pmc/articles/PMC3470020/ /pubmed/23097651 http://dx.doi.org/10.3724/SP.J.1263.2012.02143 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Ma, Xiao-Wei
Guo, Xiao-Hui
Xiao, Xin-Hua
Guo, Li-Xin
Lv, Xiao-Feng
Li, Quan-Min
Gao, Yan
spellingShingle Ma, Xiao-Wei
Guo, Xiao-Hui
Xiao, Xin-Hua
Guo, Li-Xin
Lv, Xiao-Feng
Li, Quan-Min
Gao, Yan
A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol
author_facet Ma, Xiao-Wei
Guo, Xiao-Hui
Xiao, Xin-Hua
Guo, Li-Xin
Lv, Xiao-Feng
Li, Quan-Min
Gao, Yan
author_sort Ma, Xiao-Wei
title A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol
title_short A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol
title_full A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol
title_fullStr A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol
title_full_unstemmed A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol
title_sort randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with probucol and cilostazol
description
publisher Science Press
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470020/
_version_ 1611915724605882368